Pricing and Reimbursement in U.S. Pharmaceutical Markets
In this survey chapter on pricing and reimbursement in U.S.
In this survey chapter on pricing and reimbursement in U.S.
Concerns about reducing the rate of growth of health expenditures have reignited interest in medical liability reforms and their potential to save money by reducing the practice of defensive med
Health reform can be assessed from the perspective of four groups that collectively include most Americans. For those who are now in Medicaid or who are uninsured, reform will be a major gain.
Background: Primary percutaneous coronary intervention (PCI) is more effective on average than fibrinolytic therapy (FT) in the treatment of ST-segment elevation myocardial infarction (STEMI).
We investigated whether a price increase on regular (sugary) soft drinks and an educational intervention would reduce their sales. Methods.
Research on earnings and health frequently relies on self-reported earnings (SRE) for a single year, despite repeated criticism of this measure.
The widespread geographic variation in Medicare spending has garnered a great deal of attention in the health care reform debate, both as a marker of inefficient resource use and as a window into pote
The Medicare Prescription Drug, Improvement, and Modernization Act, enacted in 2003, substantially reduced payment rates for chemotherapy drugs administered on an outpatient basis starting in Ja
Get smart & reliable public policy insights right in your inbox.